Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Study Title
Comparative Bioavailability of Myfenaxֲ® and CellCeptֲ® in Kidney Transplant Patients
Teva Identifier
116B8 | 2009-010562-31
ClinicalTrials.gov Identifier
NCT00991510
Study Status
Terminated
Trial Condition(s)
Stable Renal Transplant Recipients
Interventions
Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
08/01/2009 - 10/01/2010
Phase
Phase 4

Study Type

Interventional